SE8600998L - Parenterala fenytoinpreparat - Google Patents

Parenterala fenytoinpreparat

Info

Publication number
SE8600998L
SE8600998L SE8600998A SE8600998A SE8600998L SE 8600998 L SE8600998 L SE 8600998L SE 8600998 A SE8600998 A SE 8600998A SE 8600998 A SE8600998 A SE 8600998A SE 8600998 L SE8600998 L SE 8600998L
Authority
SE
Sweden
Prior art keywords
phenytoin
parenteral
preparation
preparations
sodium
Prior art date
Application number
SE8600998A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8600998D0 (sv
Inventor
M B Fawzi
A K Taylor
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE8600998D0 publication Critical patent/SE8600998D0/xx
Publication of SE8600998L publication Critical patent/SE8600998L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8600998A 1985-05-20 1986-03-05 Parenterala fenytoinpreparat SE8600998L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/735,932 US4642316A (en) 1985-05-20 1985-05-20 Parenteral phenytoin preparations

Publications (2)

Publication Number Publication Date
SE8600998D0 SE8600998D0 (sv) 1986-03-05
SE8600998L true SE8600998L (sv) 1986-11-21

Family

ID=24957819

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8600998A SE8600998L (sv) 1985-05-20 1986-03-05 Parenterala fenytoinpreparat

Country Status (18)

Country Link
US (1) US4642316A (it)
JP (1) JPS61268618A (it)
AU (1) AU595790B2 (it)
BE (1) BE904476A (it)
CA (1) CA1268119A (it)
CH (1) CH668594A5 (it)
DE (1) DE3610330A1 (it)
DK (1) DK100786A (it)
ES (1) ES8707195A1 (it)
FR (1) FR2581871B1 (it)
GB (1) GB2175203B (it)
IT (1) IT1190282B (it)
LU (1) LU86383A1 (it)
NL (1) NL8600899A (it)
NZ (1) NZ215783A (it)
PH (1) PH22922A (it)
SE (1) SE8600998L (it)
ZA (1) ZA862094B (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3828156A1 (de) * 1988-08-19 1990-02-22 Astrapin Pharmazeutische Praep Stabile waessrige loesung von fluorouracil
AU8479998A (en) * 1997-07-22 1999-02-16 Warner-Lambert Company Lyophilized fosphenytoin sodium for parenteral use
AU1917899A (en) 1998-03-20 1999-10-18 Warner-Lambert Company Crystalline sodium phenytoin monohydrate
US6274168B1 (en) 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
WO2004058152A2 (en) * 2002-12-16 2004-07-15 Ranbaxy Pharmaceuticals Inc. An extended release pharmaceutical composition of phenytoin sodium
EP1855760A2 (en) 2005-02-03 2007-11-21 TopoTarget UK Limited Combination therapies using hdac inhibitors
DE102005019393A1 (de) * 2005-04-25 2006-10-26 Basell Polyolefine Gmbh Polyethylenformmassen für Spritzgussanwendungen
NZ563236A (en) 2005-05-13 2010-12-24 Topotarget Uk Ltd Pharmaceutical formulations of N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide, aka PXD-101, and arginine
AU2012213940B2 (en) * 2005-05-13 2015-03-26 Topotarget Uk Limited Pharmaceutical formulations of HDAC inhibitors
US8828392B2 (en) 2005-11-10 2014-09-09 Topotarget Uk Limited Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent
CA2632198C (en) * 2005-12-05 2013-10-01 Taro Pharmaceuticals North America, Inc. Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
CA2700173C (en) * 2007-09-25 2016-10-11 Topotarget Uk Limited Methods of synthesis of certain hydroxamic acid compounds
EA022880B1 (ru) * 2008-03-07 2016-03-31 Онксео Дк, Филиал Онксео С.А., Франция Способы лечения с применением длительной непрерывной инфузии белиностата
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
DK2432454T3 (en) * 2009-05-19 2017-06-19 Neuroderm Ltd COMPOSITIONS FOR CONTINUOUS ADMINISTRATION OF DOPA DECARBOXYLASE INHIBITORS
PL3326615T3 (pl) 2010-11-15 2020-07-27 Neuroderm Ltd Ciągłe podawanie L-dopy, inhibitorów dekarboksylazy dopy, inhibitorów katecholo-o-metylotransferazy i ich kompozycji
WO2012082995A1 (en) 2010-12-15 2012-06-21 Nektar Therapeutics Oligomer-containing hydantoin compounds
HUE042425T2 (hu) 2012-06-05 2019-06-28 Neuroderm Ltd Apomorfint és szerves savakat tartalmazó készítmények és alkalmazásaik
EP4299128A3 (en) 2014-03-13 2024-04-17 Neuroderm Ltd. Dopa decarboxylase inhibitor compositions
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US12109303B2 (en) 2022-04-18 2024-10-08 ISHA Therapeutics LLC Orally dissolving antimicrobial film compositions and methods of their use
WO2023205615A1 (en) * 2022-04-18 2023-10-26 ISHA Therapeutics LLC Orally dissolving antimicrobial film compositions & methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749779A (en) * 1970-08-27 1973-07-31 American Home Prod Stable solutions of sodium diphenylhydantoin
JPS5221575B2 (it) * 1972-03-18 1977-06-11
US4163058A (en) * 1977-04-22 1979-07-31 Interx Research Corporation Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
US4260769A (en) * 1977-04-22 1981-04-07 Interx Research Corporation 5,5-Diphenylhydantoins

Also Published As

Publication number Publication date
AU5441286A (en) 1986-11-27
ES8707195A1 (es) 1987-07-16
AU595790B2 (en) 1990-04-12
IT1190282B (it) 1988-02-16
FR2581871A1 (fr) 1986-11-21
PH22922A (en) 1989-01-24
US4642316A (en) 1987-02-10
DE3610330A1 (de) 1986-11-20
GB2175203A (en) 1986-11-26
NL8600899A (nl) 1986-12-16
IT8647936A0 (it) 1986-04-24
FR2581871B1 (fr) 1990-05-11
CH668594A5 (fr) 1989-01-13
GB2175203B (en) 1988-09-14
NZ215783A (en) 1989-01-27
JPS61268618A (ja) 1986-11-28
CA1268119A (en) 1990-04-24
ZA862094B (en) 1986-11-26
ES555143A0 (es) 1987-07-16
BE904476A (fr) 1986-09-24
DK100786D0 (da) 1986-03-05
DK100786A (da) 1986-11-21
GB8607383D0 (en) 1986-04-30
LU86383A1 (fr) 1986-09-02
SE8600998D0 (sv) 1986-03-05

Similar Documents

Publication Publication Date Title
SE8600998D0 (sv) Parenterala fenytoinpreparat
DK664187D0 (da) Hydrosolpraeparater
DK18088A (da) Taetningsarrangement
DE3766958D1 (de) Isochinolin-derivate.
DK413987D0 (da) Farmaceutiske praeparater
SE8700203D0 (sv) Pyroglutamide derivatives
DE3772218D1 (de) Isochinolin-derivate.
DK401387A (da) Benzopyranderivatholdige praeparater
DK24986A (da) Allergenholdige praeparater
DK396986A (da) Parenterale phenytoin-praeparater
DE3682446D1 (de) Isochinolinderivate.
DK335587D0 (da) Vaeskefremmende veterinaerpraeparater
DK145688A (da) Skydelaas
TR23272A (tr) Katlanan sedye
DK416386A (da) Dobbeltvirkende roereorgan
DK92287D0 (da) Drivstangsbeslag
IT8721014A0 (it) 1-metansolfonilossi-6-trifluorometi l-1h-benzotriazolo e il suo impiego per preparare derivati della cefalosporina.
DK503386D0 (da) Peptidpraeparater
DK553487A (da) Baerbar projektoer
IT1206796B (it) 6-trifluorometil-1h-benzotriazol-1ile-difenilfosfato e il suo impiego per preparare derivati della cefaloscporina.
DK466086A (da) Exogent syrnede antacidiumpraeparater
AT386035B (de) Dichtung
KR870008562U (ko) 범용성 절첩식 골조 연결구
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater
DK661488D0 (da) Antitumorpraeparater

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8600998-2

Effective date: 19921001

Format of ref document f/p: F